HomeCompareKAMRF vs MRK

KAMRF vs MRK: Dividend Comparison 2026

KAMRF yields 1818.18% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KAMRF wins by $4103414683.78M in total portfolio value
10 years
KAMRF
KAMRF
● Live price
1818.18%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4103414683.84M
Annual income
$3,702,796,788,756,407.00
Full KAMRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KAMRF vs MRK

📍 KAMRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKAMRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KAMRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KAMRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KAMRF
Annual income on $10K today (after 15% tax)
$154,545.45/yr
After 10yr DRIP, annual income (after tax)
$3,147,377,270,442,946.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KAMRF beats the other by $3,147,377,270,434,617.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KAMRF + MRK for your $10,000?

KAMRF: 50%MRK: 50%
100% MRK50/50100% KAMRF
Portfolio after 10yr
$2051707341.95M
Annual income
$1,851,398,394,383,102.50/yr
Blended yield
90.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KAMRF
No analyst data
Altman Z
25.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KAMRF buys
0
MRK buys
0
No recent congressional trades found for KAMRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKAMRFMRK
Forward yield1818.18%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4103414683.84M$56.8K
Annual income after 10y$3,702,796,788,756,407.00$9,798.13
Total dividends collected$4074760433.31M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KAMRF vs MRK ($10,000, DRIP)

YearKAMRF PortfolioKAMRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$192,518$181,818.18$11,206$366.19+$181.3KKAMRF
2$3,477,331$3,271,336.99$12,650$502.35+$3.46MKAMRF
3$58,943,217$55,222,471.89$14,407$694.19+$58.93MKAMRF
4$937,891,469$874,822,227.57$16,585$967.82+$937.87MKAMRF
5$14,012,869,532$13,009,325,660.38$19,342$1,363.89+$14012.85MKAMRF
6$196,647,994,247$181,654,223,846.76$22,913$1,947.19+$196647.97MKAMRF
7$2,592,865,386,485$2,382,452,032,641.56$27,662$2,823.89+$2592865.36MKAMRF
8$32,132,661,421,271$29,358,295,457,731.54$34,159$4,173.35+$32132661.39MKAMRF
9$374,409,247,740,494$340,027,300,019,734.44$43,337$6,308.80+$374409247.70MKAMRF
10$4,103,414,683,838,736$3,702,796,788,756,407.00$56,776$9,798.13+$4103414683.78MKAMRF

KAMRF vs MRK: Complete Analysis 2026

KAMRFStock

Kalamazoo Resources Limited explores for and develops gold and base metal properties in Australia. The company also explores for nickel and cobalt deposits. It holds interests in the Castlemaine project that consists of three exploration licenses covering an area of approximately 310 square kilometers; the South Muckleford project that comprises an area of approximately 161 square kilometers; the Tarnagulla project; and the Myrtle project located in Victoria. The company also holds interests in the Pilbara projects, including the Ashburton project comprising 4 mining leases and 3 exploration licenses covering an area of approximately 217 square kilometers; the DOM's Hill project that covers an area of approximately 125 square kilometers; the Marble Bar project covering an area of approximately 125 square kilometers; the Pear Creek lithium project covering an area of approximately 147 square kilometers; and the Sisters project covering an area of approximately 239 square kilometers situated in Western Australia. Kalamazoo Resources Limited was incorporated in 2011 and is headquartered in West Perth, Australia.

Full KAMRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KAMRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KAMRF vs SCHDKAMRF vs JEPIKAMRF vs OKAMRF vs KOKAMRF vs MAINKAMRF vs JNJKAMRF vs ABBVKAMRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.